Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Scribe Therapeutics
Biotech
Sanofi, Scribe seal new in vivo collab worth more than $1.2B
Sanofi and Scribe have sealed a second partnership in less than a year, with the latest pact focused on developing in vivo gene editing therapies.
Max Bayer
Jul 17, 2023 11:30am
Scribe's CRISPR tech Prevails with new $1.5B Lilly biobucks deal
May 16, 2023 9:00am
Sanofi pays Scribe $25M for CRISPR NK cell therapy project
Sep 27, 2022 8:15am
J&J's Mammen abruptly leaves top R&D job—Chutes & Ladders
Aug 12, 2022 9:30am
Biogen takes another dip into Scribe gene therapy collab
May 2, 2022 3:03pm
Scribe snags $100M for engineered CRISPR tech, pipeline
Mar 31, 2021 10:00am
